Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Manuskript / Papierantiquität
EUR 9,20
Anzahl: 1 verfügbar
In den Warenkorbpamphlet. Zustand: Brand New. 56 pages. 5.79x0.35x8.03 inches. In Stock.
Sprache: Englisch
Verlag: S. Karger AG, Verlag für Medizin und, 2025
ISBN 10: 3318072591 ISBN 13: 9783318072594
Anbieter: moluna, Greven, Deutschland
Zustand: New.
sonst. Bücher. Zustand: Neu. Neuware - Pyruvate kinase deficiency (PK deficiency) is a rare genetic disease that causes red blood cells to break apart easily (hemolysis). Some patients have no or few symptoms; others have very low numbers of red blood cells (hemolytic anemia) and need treatment with regular blood transfusions. Hemolysis occurs in everyone with PK deficiency. It increases the risk of complications that need monitoring, such as gallstones, iron overload, and low bone density. Treatment with mitapivat, which is taken as a tablet, activates pyruvate kinase and reduces anemia and hemolysis in about half of all adults with PK deficiency. Research into other new treatments, including gene therapy, is promising. Common supportive treatments include blood transfusions, removal of the spleen (splenectomy), and medications to remove excess iron from the blood (chelation therapy).
Zustand: Neu. Fast Facts for Patients: Pyruvate Kinase Deficiency | Rachael Grace | Broschüre | Englisch | 2025 | Karger Verlag | EAN 9783318072594 | Verantwortliche Person für die EU: Karger Verlag, Schnewlinstr. 12, 79098 Freiburg, information[at]karger[dot]com | Anbieter: preigu.
Zustand: Gut. Zustand: Gut | Seiten: 55 | Sprache: Englisch | Produktart: Bücher | Pyruvate kinase deficiency (PK deficiency) is a rare genetic disease that causes red blood cells to break apart easily (hemolysis). Some patients have no or few symptoms; others have very low numbers of red blood cells (hemolytic anemia) and need treatment with regular blood transfusions. Hemolysis occurs in everyone with PK deficiency. It increases the risk of complications that need monitoring, such as gallstones, iron overload, and low bone density. Treatment with mitapivat, which is taken as a tablet, activates pyruvate kinase and reduces anemia and hemolysis in about half of all adults with PK deficiency. Research into other new treatments, including gene therapy, is promising. Common supportive treatments include blood transfusions, removal of the spleen (splenectomy), and medications to remove excess iron from the blood (chelation therapy).